Studies on the Mode of Action of Somatostatin on Insulin Secretion
- 1 November 1977
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 101 (5) , 1436-1443
- https://doi.org/10.1210/endo-101-5-1436
Abstract
The effect of somatostatin on insulin release by incubated slices of rat pancreas was studied. Somatostatin inhibited insulin release induced by arginine/glucose (A/G), glucagon, glibenclamide, pentoxifyllin, (c[cyclic]AMP), phenotolamine and KCl. When A/G was used as a stimulus, the quantal inhibitory effect of somatostatin was not neutralized by progressively increasing glucose concentrations. The .alpha. adrenergic blocking agent phentolamine, the phosphodiesterase inhibitors theophylline (10 mM) or pentoxifyllin (10 mM), and KCl partially reversed the inhibitory effect of somatostatin on A/G stimulation. The maximal reversal of somatostatin inhibition was obtained when the slices of pancreas were stimulated with A/G in the presence of the calcium ionophore A23187 plus ATP. These results suggest that the inhibitory effect of somatostatin on insulin secretion could result from Ca translocation in pancreatic .beta. cells.This publication has 3 references indexed in Scilit:
- Requirement for calcium ion in insulin secretion by the perfused rat pancreasAmerican Journal of Physiology-Legacy Content, 1967
- An adrenergic receptor mechanism for the control of cyclic 3′5′ adenosine monophosphate synthesis in tissuesBiochemical and Biophysical Research Communications, 1967
- Coated Charcoal Immunoassay of InsulinJournal of Clinical Endocrinology & Metabolism, 1965